These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
482 related articles for article (PubMed ID: 22705273)
1. Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments. Löscher W; Puskarjov M; Kaila K Neuropharmacology; 2013 Jun; 69():62-74. PubMed ID: 22705273 [TBL] [Abstract][Full Text] [Related]
2. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures. Kahle KT; Staley KJ Neurosurg Focus; 2008 Sep; 25(3):E22. PubMed ID: 18759624 [TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizures. Puskarjov M; Kahle KT; Ruusuvuori E; Kaila K Epilepsia; 2014 Jun; 55(6):806-18. PubMed ID: 24802699 [TBL] [Abstract][Full Text] [Related]
4. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Dzhala VI; Brumback AC; Staley KJ Ann Neurol; 2008 Feb; 63(2):222-35. PubMed ID: 17918265 [TBL] [Abstract][Full Text] [Related]
5. Role of NKCC1 and KCC2 in the development of chronic neuropathic pain following spinal cord injury. Hasbargen T; Ahmed MM; Miranpuri G; Li L; Kahle KT; Resnick D; Sun D Ann N Y Acad Sci; 2010 Jun; 1198():168-72. PubMed ID: 20536931 [TBL] [Abstract][Full Text] [Related]
6. The K+-Cl cotransporter KCC2 promotes GABAergic excitation in the mature rat hippocampus. Viitanen T; Ruusuvuori E; Kaila K; Voipio J J Physiol; 2010 May; 588(Pt 9):1527-40. PubMed ID: 20211979 [TBL] [Abstract][Full Text] [Related]
7. Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex. Conti L; Palma E; Roseti C; Lauro C; Cipriani R; de Groot M; Aronica E; Limatola C Epilepsia; 2011 Sep; 52(9):1635-44. PubMed ID: 21635237 [TBL] [Abstract][Full Text] [Related]
8. Role of NKCC1 and KCC2 in Epilepsy: From Expression to Function. Liu R; Wang J; Liang S; Zhang G; Yang X Front Neurol; 2019; 10():1407. PubMed ID: 32010056 [TBL] [Abstract][Full Text] [Related]
9. Roles of the cation-chloride cotransporters in neurological disease. Kahle KT; Staley KJ; Nahed BV; Gamba G; Hebert SC; Lifton RP; Mount DB Nat Clin Pract Neurol; 2008 Sep; 4(9):490-503. PubMed ID: 18769373 [TBL] [Abstract][Full Text] [Related]
10. Differential expression patterns of chloride transporters, Na+-K+-2Cl--cotransporter and K+-Cl--cotransporter, in epilepsy-associated malformations of cortical development. Aronica E; Boer K; Redeker S; Spliet WG; van Rijen PC; Troost D; Gorter JA Neuroscience; 2007 Mar; 145(1):185-96. PubMed ID: 17207578 [TBL] [Abstract][Full Text] [Related]
11. Fructose-1,6-diphosphate protects against epileptogenesis by modifying cation-chloride co-transporters in a model of amygdaloid-kindling temporal epilepticus. Ding Y; Wang S; Jiang Y; Yang Y; Zhang M; Guo Y; Wang S; Ding MP Brain Res; 2013 Nov; 1539():87-94. PubMed ID: 24095797 [TBL] [Abstract][Full Text] [Related]
13. Cation-chloride cotransporters and GABA-ergic innervation in the human epileptic hippocampus. Muñoz A; Méndez P; DeFelipe J; Alvarez-Leefmans FJ Epilepsia; 2007 Apr; 48(4):663-73. PubMed ID: 17319917 [TBL] [Abstract][Full Text] [Related]
14. Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy. Brandt C; Seja P; Töllner K; Römermann K; Hampel P; Kalesse M; Kipper A; Feit PW; Lykke K; Toft-Bertelsen TL; Paavilainen P; Spoljaric I; Puskarjov M; MacAulay N; Kaila K; Löscher W Neuropharmacology; 2018 Dec; 143():186-204. PubMed ID: 30248303 [TBL] [Abstract][Full Text] [Related]
15. Cl- uptake promoting depolarizing GABA actions in immature rat neocortical neurones is mediated by NKCC1. Yamada J; Okabe A; Toyoda H; Kilb W; Luhmann HJ; Fukuda A J Physiol; 2004 Jun; 557(Pt 3):829-41. PubMed ID: 15090604 [TBL] [Abstract][Full Text] [Related]
16. The search for NKCC1-selective drugs for the treatment of epilepsy: Structure-function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A. Lykke K; Töllner K; Feit PW; Erker T; MacAulay N; Löscher W Epilepsy Behav; 2016 Jun; 59():42-9. PubMed ID: 27088517 [TBL] [Abstract][Full Text] [Related]
17. Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1. Kahle KT; Barnett SM; Sassower KC; Staley KJ J Child Neurol; 2009 May; 24(5):572-6. PubMed ID: 19406757 [TBL] [Abstract][Full Text] [Related]
18. The extracellular space and epileptic activity in the adult brain: explaining the antiepileptic effects of furosemide and bumetanide. Hochman DW Epilepsia; 2012 Jun; 53 Suppl 1(Suppl 1):18-25. PubMed ID: 22612805 [TBL] [Abstract][Full Text] [Related]
19. Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy. Brandt C; Nozadze M; Heuchert N; Rattka M; Löscher W J Neurosci; 2010 Jun; 30(25):8602-12. PubMed ID: 20573906 [TBL] [Abstract][Full Text] [Related]
20. Developmental patterns in the regulation of chloride homeostasis and GABA(A) receptor signaling by seizures. Galanopoulou AS Epilepsia; 2007; 48 Suppl 5():14-8. PubMed ID: 17910576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]